|
LPIN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84609999999141E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.47479999995848E-06 |
| Normal-vs-Stage2 |
1.642980E-03 |
| Normal-vs-Stage3 |
3.823800E-01 |
| Normal-vs-Stage4 |
2.281300E-03 |
| Stage1-vs-Stage2 |
7.779000E-01 |
| Stage1-vs-Stage3 |
5.010800E-01 |
| Stage1-vs-Stage4 |
6.476200E-01 |
| Stage2-vs-Stage3 |
5.931400E-01 |
| Stage2-vs-Stage4 |
5.588200E-01 |
| Stage3-vs-Stage4 |
4.129600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50680999999597E-05 |
| Normal-vs-AfricanAmerican |
2.998000E-03 |
| Normal-vs-Asian |
2.952800E-01 |
| Caucasian-vs-AfricanAmerican |
3.299000E-01 |
| Caucasian-vs-Asian |
4.430000E-01 |
| AfricanAmerican-vs-Asian |
6.502200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90275999999434E-05 |
| Normal-vs-Female |
3.578400E-04 |
| Male-vs-Female |
4.965000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.16439999864326E-08 |
| Normal-vs-Extreme_Weight |
9.29100130164784E-11 |
| Normal-vs-Obese |
1.030380E-01 |
| Normal-vs-Extreme_Obese |
2.158000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.876600E-01 |
| Normal_Weight-vs-Obese |
1.746240E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.011600E-01 |
| Extreme_Weight-vs-Obese |
3.000200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.625800E-01 |
| Obese-vs-Extreme_Obese |
8.246800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.754200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.002800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.24779999946634E-07 |
| Normal-vs-Age(81-100Yrs) |
4.29470000000709E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.897200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.698900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.379500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.227990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.172300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.651600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.373190E-04 |
| Normal-VS-Type2 PRCC |
3.24649995775417E-09 |
| Normal-VS-KIRP CIMP |
4.813200E-01 |
| Normal-VS-Unclassified PRCC |
7.471500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.560100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.497200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.492600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.55389999999733E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.136750E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.523400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.19840000000349E-05 |
| Normal-vs-N1 |
1.561930E-03 |
| Normal-vs-N2 |
1.835170E-03 |
| N0-vs-N1 |
3.702000E-01 |
| N0-vs-N2 |
4.164200E-01 |
| N1-vs-N2 |
9.738200E-02 |
|
|
